news

Ghent, Belgium [November 22, 2019] – Indigo Diabetes NV, a medical device company creating next-gen sensors for diabetes healthcare, today announced it has received ISO 13485 certification from TÜV Süd for the Design and Development of Biomarker Sensing Devices and...

Indigo is pleased to announce that the first patient has now been enrolled into ‘Action-1”, the company’s prospective, non-randomized, interventional, multi-center data collection study. The study collects venous blood samples in male T1D patients to evaluate the...